Evidence map›Paper›PMID 21814183›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2011

Overexpression of Reelin prevents the manifestation of behavioral phenotypes related to schizophrenia and bipolar disorder.

Cátia M Teixeira, Eduardo D Martín, Ignasi Sahún, Nuria Masachs, Lluís Pujadas, André Corvelo, Carles Bosch, Daniela Rossi, Albert Martinez, Rafael Maldonado and 2 more

Open access · hybridAbstract readComparative Study
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 1 synthesis or guideline pooled it, 100 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Fast-acting antidepressant-like effects of Reelin evaluated in the repeated-corticosterone chronic stress paradigm.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2020
    Article
  18. Article
  19. TheJournal of clinical medicine · 2019
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 8 institutions in 1 country.

Cátia M TeixeiraDevelopmental Neurobiology and Regeneration Unit, Institute for Research in Biomedicine, Parc Cientific de Barcelona, University of Barcelona, Barcelona, Spain.
Eduardo D Martín
Ignasi Sahún
Nuria Masachs
Lluís Pujadas
André Corvelo
Carles Bosch
Daniela Rossi
Albert Martinez
Rafael Maldonado
Mara Dierssen
Eduardo Soriano
Universitat de Barcelona · ESBiomedical Research Networking Center on Neurodegenerative Diseases · ESBarcelona Biomedical Research Park · ESCentre for Biomedical Network Research on Rare Diseases · ESCentro Nacional de Análisis Genómico · ESInstitute for Research in Biomedicine · ESPompeu Fabra University · ESUniversity of Castilla-La Mancha · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite the impact of schizophrenia and mood disorders, which in extreme cases can lead to death, recent decades have brought little progress in the development of new treatments. Recent studies have shown that Reelin, an extracellular protein that is critical for neuronal development, is reduced in schizophrenia and bipolar disorder patients. However, data on a causal or protective role of Reelin in psychiatric diseases is scarce. In order to study the direct influence of Reelin's levels on behavior, we subjected two mouse lines, in which Reelin levels are either reduced (Reelin heterozygous mice) or increased (Reelin overexpressing mice), to a battery of behavioral tests: open-field, black-white box, novelty-suppressed-feeding, forced-swim-test, chronic corticosterone treatment followed by forced-swim-test, cocaine sensitization and pre-pulse inhibition (PPI) deficits induced by N-methyl-D-aspartate (NMDA) antagonists. These tests were designed to model some aspects of psychiatric disorders such as schizophrenia, mood, and anxiety disorders. We found no differences between Reeler heterozygous mice and their wild-type littermates. However, Reelin overexpression in the mouse forebrain reduced the time spent floating in the forced-swim-test in mice subjected to chronic corticosterone treatment, reduced behavioral sensitization to cocaine, and reduced PPI deficits induced by a NMDA antagonist. In addition, we demonstrate that while stress increased NMDA NR2B-mediated synaptic transmission, known to be implicated in depression, Reelin overexpression significantly reduced it. Together, these results point to the Reelin signaling pathway as a relevant drug target for the treatment of a range of psychiatric disorders.

Indexed as

Gene Expression RegulationPhenotypeAnimalsBipolar DisorderCell Adhesion Molecules, NeuronalCocaineCorticosteroneExploratory BehaviorExtracellular Matrix ProteinsFemaleMaleMiceMice, Inbred C57BLMice, Neurologic MutantsMice, TransgenicNerve Tissue ProteinsCell Adhesion Molecules, NeuronalCocaineCorticosteroneExtracellular Matrix ProteinsNerve Tissue ProteinsReelin ProteinReln protein, mouseSerine Endopeptidases

Identifiers

PMID21814183
PMCPMC3194085
OpenAlexW2015445848

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.